Editorial companion

What stands out

A scrapped SpaceX Starship test flight and HSBC’s upgrade of Apple were the headline hooks, but the sharper market takeaway came from Intuitive Surgical’s earnings and the glucagon-like peptide-1 (GLP-1) conversation. Intuitive still reports healthy profit and revenue expansion even as obesity drug trends subtly reshape procedure timing, while Apple’s upgrade lands against single-digit revenue growth that looks more comfort than conviction. The clip is a neat reminder that headlines move sentiment quickly, while earnings and secular demand patterns determine multi-year returns.